Card Factory plc (CRFCF)

SpringWorks Therapeutics Income Statement

Financials in millions GBP. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Revenue	542.5	510.9	463.4	364.4	285.1
Revenue Growth (YoY)	6.19%	10.25%	27.17%	27.82%	-36.85%
Cost of Revenue	349.6	326	302.7	247.9	205.7
Gross Profit	192.9	184.9	160.7	116.5	79.4
Selling, General & Admin	112.5	109.4	48.7	38.9	33.6
Operating Expenses	112.5	109.4	94.1	87.9	84.3
Operating Income	80.4	75.5	66.6	28.6	-4.9
Interest Expense	-14.9	-13.4	-11.4	-20.5	-8.9
Interest & Investment Income	0.2	-	-	-	-
EBT Excluding Unusual Items	65.7	62.1	55.2	8.1	-13.8
Merger & Restructuring Charges	-2.6	-	-	-	-
Asset Writedown	-	-1.1	-2.8	-5	-2.6
Other Unusual Items	1	4.6	-	8	-
Pretax Income	64.1	65.6	52.4	11.1	-16.4
Income Tax Expense	16.3	16.1	8.2	3	-2.8
Net Income	47.8	49.5	44.2	8.1	-13.6
Net Income to Common	47.8	49.5	44.2	8.1	-13.6
Net Income Growth	-3.43%	11.99%	445.68%	-	-
Shares Outstanding (Basic)	347	343	342	342	342
Shares Outstanding (Diluted)	349	347	344	344	342
Shares Change (YoY)	0.55%	0.97%	0.09%	0.54%	0.05%
EPS (Basic)	0.14	0.14	0.13	0.02	-0.04
EPS (Diluted)	0.14	0.14	0.13	0.02	-0.04
EPS Growth	-4.20%	11.72%	440.08%	-	-
Free Cash Flow	77.5	86.4	91.1	110.1	68.7
Free Cash Flow Per Share	0.22	0.25	0.27	0.32	0.20
Dividend Per Share	0.048	0.045	-	-	-
Dividend Growth	6.67%	-	-	-	-
Gross Margin	35.56%	36.19%	34.68%	31.97%	27.85%
Operating Margin	14.82%	14.78%	14.37%	7.85%	-1.72%
Profit Margin	8.81%	9.69%	9.54%	2.22%	-4.77%
Free Cash Flow Margin	14.29%	16.91%	19.66%	30.21%	24.10%
EBITDA	89.4	83.1	74.6	37.4	4.3
EBITDA Margin	16.48%	16.27%	16.10%	10.26%	1.51%
D&A For EBITDA	9	7.6	8	8.8	9.2
EBIT	80.4	75.5	66.6	28.6	-4.9
EBIT Margin	14.82%	14.78%	14.37%	7.85%	-1.72%
Effective Tax Rate	25.43%	24.54%	15.65%	27.03%	-

Updated Sep 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.